BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jepsen P. Comorbidity in cirrhosis. World J Gastroenterol 2014; 20(23): 7223-7230 [PMID: 24966593 DOI: 10.3748/wjg.v20.i23.7223]
URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7223.htm
Number Citing Articles
1
Nida Choudry, Roula Sasso, Don C. Rockey. Infection in Hospitalized Cirrhosis Patients: Changing Epidemiology and Clinical FeaturesThe American Journal of the Medical Sciences 2022; 363(2): 114 doi: 10.1016/j.amjms.2021.10.023
2
Dennis Hundersmarck, Olivier Q. Groot, Henk J. Schuijt, Falco Hietbrink, Luke P. H. Leenen, Marilyn Heng. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased MortalityClinical Orthopaedics & Related Research 2022; 480(6): 1077 doi: 10.1097/CORR.0000000000002088
3
Jeffrey S. Barrett. Fundamentals of Drug Development2022; : 199 doi: 10.1002/9781119913276.ch10
4
Ashley Hodgson, Thomas Bernardin, Benjamin Westermeyer, Ella Hagopian, Tyler Radtke, Ahmed Noman. Development of a specialty intensity score to estimate a patient's need for care coordination across physician specialtiesHealth Science Reports 2021; 4(2) doi: 10.1002/hsr2.303
5
Roula Sasso, Don C. Rockey. Non‐selective beta‐blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infectionAlimentary Pharmacology & Therapeutics 2021; 53(3): 418 doi: 10.1111/apt.16156
6
Peng Hu, Jinwei Guo, Benhuo Zhao, Zhixiang Zhang, Jincan Zhu, Feng Liu. CircCHD2/miR-200b-3p/HLF Axis Promotes Liver Cirrhosis Journal of Environmental Pathology, Toxicology and Oncology 2022; 41(4): 1 doi: 10.1615/JEnvironPatholToxicolOncol.2022041823
7
Hsin-Yun Wu, Chao-Shun Lin, Chun-Chieh Yeh, Chaur-Jong Hu, Chun-Chuan Shih, Yih-Giun Cherng, Ta-Liang Chen, Chien-Chang Liao. Cirrhosis patients' stroke risks and adverse outcomes: Two nationwide studiesAtherosclerosis 2017; 263: 29 doi: 10.1016/j.atherosclerosis.2017.05.030
8
Jianping Xiong, Weiyu Xu, Hanchun Huang, Jin Bian, Anqiang Wang, Yi Bai, Jianzhen Lin, Yiyao Xu, Xin Lu, Haitao Zhao. Cirrhosis and risk of stroke: A systematic review and meta-analysisAtherosclerosis 2018; 275: 296 doi: 10.1016/j.atherosclerosis.2018.06.876
9
Iulia Raţiu, Raluca Lupuşoru, Alina Popescu, Ioan Sporea, Adrian Goldiş, Mirela Dănilă, Bogdan Miuţescu, Tudor Moga, Andreea Barbulescu, Roxana Şirli. Acute gastrointestinal bleeding: A comparison between variceal and nonvariceal gastrointestinal bleedingMedicine 2022; 101(45): e31543 doi: 10.1097/MD.0000000000031543
10
Jella-Andrea Abraham, Olga Golubnitschaja. Time for Paradigm Change in Management of Hepatocellular Carcinoma: Is a Personalized Approach on the Horizon?Personalized Medicine 2016; 13(5): 455 doi: 10.2217/pme-2016-0013
11
Qiu-Yu Cai, Kun Tan, Xue-Li Zhang, Xu Han, Jing-Ping Pan, Zhi-Yin Huang, Cheng-Wei Tang, Jing Li. Incidence, prevalence, and comorbidities of chronic pancreatitis: A 7-year population-based studyWorld Journal of Gastroenterology 2023; 29(30): 4671-4684 doi: 10.3748/wjg.v29.i30.4671
12
Xiao-Min Mu, Wei Wang, Yu-Ying Jiang, Jia Feng. Patterns of Comorbidity in Hepatocellular Carcinoma: A Network PerspectiveInternational Journal of Environmental Research and Public Health 2020; 17(9): 3108 doi: 10.3390/ijerph17093108
13
F. I. Belialov. Selection of medications in comorbidityThe Russian Archives of Internal Medicine 2020; 10(1): 57 doi: 10.20514/2226-6704-2020-10-1-57-60
14
Marco Vincenzo Lenti, Alessia Ballesio, Gabriele Croce, Alice Silvia Brera, Lucia Padovini, Giampiera Bertolino, Antonio Di Sabatino, Catherine Klersy, Gino Roberto Corazza. Comorbidity and multimorbidity in patients with cirrhosis, hospitalised in an internal medicine ward: a monocentric, cross-sectional studyBMJ Open 2024; 14(5): e077576 doi: 10.1136/bmjopen-2023-077576
15
Kelly L. Hayward, Rianne A. Weersink. Improving Medication‐Related Outcomes in Chronic Liver DiseaseHepatology Communications 2020; 4(11): 1562 doi: 10.1002/hep4.1612
16
Salma N Fahmy, Lobna H Khedr, Sara A Wahdan, Esther T Menze, Samar S Azab, Ebtehal El-Demerdash. Effect of carvedilol on pharmacokinetics of sofosbuvir and its metabolite GS-331007: role of P-glycoproteinJournal of Pharmacy and Pharmacology 2024; 76(8): 1051 doi: 10.1093/jpp/rgae070
17
Jakub Hoferica, Ruben Zsolt Borbély, Ali Nedjati Aghdam, Eszter Ágnes Szalai, Ádám Zolcsák, Dániel Sándor Veres, Krisztina Hagymási, Bálint Erőss, Péter Hegyi, Peter Bánovčin, Péter Jenő Hegyi. Chronic liver disease is an important risk factor for worse outcomes in acute pancreatitis: a systematic review and meta-analysisScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-66710-w
18
Antonio De Vincentis, Giorgio Pennazza, Marco Santonico, Umberto Vespasiani‐Gentilucci, Giovanni Galati, Paolo Gallo, Alessandro Zompanti, Claudio Pedone, Raffaele Antonelli Incalzi, Antonio Picardi. Breath‐print analysis by e‐nose may refine risk stratification for adverse outcomes in cirrhotic patientsLiver International 2017; 37(2): 242 doi: 10.1111/liv.13214
19
Yuliia Ya. Fedulenkova, Mykhailo S. Myroshnychenko, Olha M. Astapieva, Aleksandr A. Fatieiev, Kristina Od. Akritova, Dmytro V. Molodan. CHARACTERISTICS OF AUTOPSY MATERIAL IN CASES OF CHRONIC DIFFUSE PATHOLOGY OF THE LIVER PARENCHYMA DIAGNOSED DURING PATIENT’S LIFETIME USING THE ULTRASOUND METHODWiadomości Lekarskie 2020; 73(9): 1995 doi: 10.36740/WLek202009218
20
Roula Sasso, Ahmad Abou Yassine, Liliane Deeb. Predictors of Development of Hepatorenal Syndrome in Hospitalized Cirrhotic Patients with Acute Kidney InjuryJournal of Clinical Medicine 2021; 10(23): 5621 doi: 10.3390/jcm10235621
21
M. Gahramanova. THE USE OF HERBAL REMEDIES IN THE TREATMENT OF HEPATOBILIARY DISEASES: TRENDS AND PROSPECTSBiotechnologia acta 2019; 12(5): 42 doi: 10.15407/biotech12.05.042
22
M.V. Lytvynenko. Influence of HIV infection and alcohol abuse on the morphological structure of the uterine tubeMedicine Today and Tomorrow 2021; 90(3) doi: 10.35339/msz.2021.90.3.lyt
23
Blerina Shkodra, Adrian T. Press, Antje Vollrath, Ivo Nischang, Stephanie Schubert, Stephanie Hoeppener, Dorothee Haas, Christoph Enzensperger, Marc Lehmann, Petra Babic, Kay Jovana Benecke, Anja Traeger, Michael Bauer, Ulrich S. Schubert. Formulation of Liver-Specific PLGA-DY-635 Nanoparticles Loaded with the Protein Kinase C Inhibitor Bisindolylmaleimide IPharmaceutics 2020; 12(11): 1110 doi: 10.3390/pharmaceutics12111110
24
Sumeet K. Asrani, Lauren Hall, Vikrant Reddy, Gerald Ogola, Manhal Izzy. Comorbid Chronic Diseases and Survival in Compensated and Decompensated Cirrhosis: A Population-Based StudyAmerican Journal of Gastroenterology 2022; 117(12): 2009 doi: 10.14309/ajg.0000000000001909
25
Marika Rudler, Vincenzo La Mura. Portal Hypertension VI2016; : 205 doi: 10.1007/978-3-319-23018-4_22
26
Shari S. Rogal, Vera Yakovchenko, Rachel Gonzalez, Angela Park, Carolyn Lamorte, Sandra P. Gibson, Maggie Chartier, David Ross, Emily Comstock, Jasmohan S. Bajaj, Timothy R. Morgan, Hans Tillmann. Characterizing patient-reported outcomes in veterans with cirrhosisPLOS ONE 2020; 15(9): e0238712 doi: 10.1371/journal.pone.0238712
27
Kittiyod Poovorawan, Sombat Treeprasertsuk, Kaewjai Thepsuthammarat, Polrat Wilairatana, Bubpha Kitsahawong, Kamthorn Phaosawasdi. The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide studyAnnals of Hepatology 2015; 14(6): 862 doi: 10.5604/16652681.1171773
28
Ankur A Dashputre, Branden D Nemecek, Khalid M Kamal, Jordan R Covvey. The relationship between a cirrhosis‐specific comorbidity scoring system and healthcare utilization patternsJournal of Gastroenterology and Hepatology 2019; 34(7): 1222 doi: 10.1111/jgh.14531
29
Eden Koo, Amit G. Singal. Hepatocellular Carcinoma SurveillanceSurgical Oncology Clinics of North America 2024; 33(1): 13 doi: 10.1016/j.soc.2023.06.005
30
Aidan Spring, Jagroop S. Saran, Sinead McCarthy, Stuart A. McCluskey. Anesthesia for the Patient with Severe Liver FailureAdvances in Anesthesia 2020; 38: 251 doi: 10.1016/j.aan.2020.09.002
31
Aidan Spring, Jagroop S. Saran, Sinead McCarthy, Stuart A. McCluskey. Anesthesia for the Patient with Severe Liver FailureAnesthesiology Clinics 2020; 38(1): 35 doi: 10.1016/j.anclin.2019.10.002
32
Leonn Mendes Soares Pereira, Ednelza da Silva Graça Amoras, Simone Regina Souza da Silva Conde, Sâmia Demachki, Eduardo José Melo dos Santos, Sandra Souza Lima, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. NGF (−198C > T, Ala35Val) and p75NTR (Ser205Leu) gene mutations are associated with liver function in different histopathological profiles of the patients with chronic viral hepatitis in the Brazilian AmazonMolecular Medicine 2020; 26(1) doi: 10.1186/s10020-019-0134-x
33
Naoya Murashima. Clinical Investigation of Portal Hypertension2019; : 185 doi: 10.1007/978-981-10-7425-7_16
34
Tae Wook Kang, Sun-Young Kong, Danbee Kang, Min Woong Kang, Young Kon Kim, Seong Hyun Kim, Dong Hyun Sinn, Young Ae Kim, Kui Son Choi, Eun Sook Lee, Sang Myung Woo, Joung Hwan Back, Eliseo Guallar, Juhee Cho. Use of Gadoxetic Acid–enhanced Liver MRI and Mortality in More than 30 000 Patients with Hepatocellular Carcinoma: A Nationwide AnalysisRadiology 2020; 295(1): 114 doi: 10.1148/radiol.2020190639
35
Na Wang, Pei Li, Dandan Suo, Hongyan Wei, Huanhuan Wei, Run Guo, Wen Si. A Predictive Model for Identifying Low Medication Adherence Among Patients with CirrhosisPatient Preference and Adherence 2023; : 2749 doi: 10.2147/PPA.S426844
36
Adil Vural, Amy Attaway, Nicole Welch, Joe Zein, Srinivasan Dasarathy. Skeletal muscle loss phenotype in cirrhosis: A nationwide analysis of hospitalized patientsClinical Nutrition 2020; 39(12): 3711 doi: 10.1016/j.clnu.2020.03.032
37
Jonathan I. Quinlan, Amritpal Dhaliwal, Felicity Williams, Sophie L. Allen, Leigh Breen, Carolyn A. Greig, Janet M. Lord, Matthew J. Armstrong, Ahmed M. Elsharkawy. Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver DiseaseFrontiers in Physiology 2022; 12 doi: 10.3389/fphys.2021.817152
38
M. M. Lauridsen, L. Poulsen, C. K. Rasmussen, M. Høgild, M.K. Nielsen, O. B. Schaffalitzky de Muckadell, H. Vilstrup. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathyMetabolic Brain Disease 2016; 31(2): 267 doi: 10.1007/s11011-015-9741-6
39
Marika Rudler, Clémence Marois, Nicolas Weiss, Dominique Thabut, Vincent Navarro. Status epilepticus in patients with cirrhosis: How to avoid misdiagnosis in patients with hepatic encephalopathySeizure 2017; 45: 192 doi: 10.1016/j.seizure.2016.12.011
40
Samreen Huma, Omer Nishat Fatima, Ishrath Ayesha, Jamal Mohammed Moiz, Shareef Mohammed Mohiuddin. Prescribing Pattern of Drugs Used in Chronic Liver Disease with Co Morbid Conditions and Assessment of Severity using MELD Score: A Prospective Observational StudyJournal of Drug Delivery and Therapeutics 2020; 10(5-s): 19 doi: 10.22270/jddt.v10i5-s.4436
41
Murat DAŞ, Okan BARDAKCI, Gökhan AKDUR, İmran KANKAYA, Coşkun BAKAR, Okhan AKDUR, Yavuz BEYAZIT. Prediction of mortality with Charlson Comorbidity Index in super-elderly patients admitted to a tertiary referral hospitalCukurova Medical Journal 2022; 47(1): 199 doi: 10.17826/cumj.1017164
42
Tammo L. Tergast, Hans Laser, Svetlana Gerbel, Michael. P. Manns, Markus Cornberg, Benjamin Maasoumy. Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and AscitesClinical and Translational Gastroenterology 2018; 9(9): e189 doi: 10.1038/s41424-018-0053-0
43
Mindie H. Nguyen. ReplyHepatology 2020; 71(4): 1519 doi: 10.1002/hep.30560
44
Xin-Xing Tantai, Na Liu, Long-Bao Yang, Zhong-Cao Wei, Cai-Lan Xiao, Ya-Hua Song, Jin-Hai Wang. Prognostic value of risk scoring systems for cirrhotic patients with variceal bleedingWorld Journal of Gastroenterology 2019; 25(45): 6668-6680 doi: 10.3748/wjg.v25.i45.6668
45
Chaitanya Pant, Mojtaba Olyaee, Richard Gilroy, Prashant K. Pandya, Jody C. Olson, Melissa Oropeza-Vail, Tarun Rai, Abhishek Deshpande. Emergency Department Visits Related to CirrhosisMedicine 2015; 94(1): e308 doi: 10.1097/MD.0000000000000308
46
Tanay S. Samant, Shu Yang, Michelle Miller, Yan Ji. Pharmacokinetics of Ribociclib in Subjects With Hepatic ImpairmentThe Journal of Clinical Pharmacology 2021; 61(8): 1001 doi: 10.1002/jcph.1825
47
Anna Licata, Giuseppina Novo, Daniela Colomba, Antonino Tuttolomondo, Massimo Galia, Calogero Camma’. Cardiac involvement in patients with cirrhosisJournal of Cardiovascular Medicine 2016; 17(1): 26 doi: 10.2459/JCM.0000000000000288
48
Shuang Yu, Yu Long, Dan Li, Ai Shi, Jie Deng, Yin Ma, Jing Wen, Xiaoqiu Li, Yulu Zhang, Songyu Liu, Jinyan Wan, Nan Li, Jinlin Guo. Natural essential oils efficacious in internal organs fibrosis treatment: Mechanisms of action and application perspectivesPharmacological Research 2022; 182: 106339 doi: 10.1016/j.phrs.2022.106339
49
Mehdi Saberifiroozi. Improving Quality of Care in Patients with Liver CirrhosisMiddle East Journal of Digestive Diseases 2017; 9(4): 189 doi: 10.15171/mejdd.2017.73
50
Roula Sasso, Steven Lauzon, Don C. Rockey. Cirrhotic Patients on Mechanical Ventilation Have a Low Rate of Successful Extubation and SurvivalDigestive Diseases and Sciences 2020; 65(12): 3744 doi: 10.1007/s10620-020-06051-6
51
Asim Kichloo, Zain El-Amir, Dushyant Singh Dahiya, Farah Wani, Jagmeet Singh, Dhanshree Solanki, Ehizogie Edigin, Precious Eseaton, Asad Mehboob, Hafeez Shaka. Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissionsWorld Journal of Hepatology 2021; 13(12): 2128-2136 doi: 10.4254/wjh.v13.i12.2128
52
Harold I. Zeliger. Oxidative Stress2023; : 359 doi: 10.1016/B978-0-323-91890-9.00032-5